Share Name Share Symbol Market Type Share ISIN Share Description
Summit Corporation LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +7.50p +3.85% 202.50p 195.00p 210.00p 202.50p 197.50p 197.50p 10,761 11:01:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.4 -20.1 -28.8 - 125.40

Summit Corp Share Discussion Threads

Showing 38626 to 38650 of 38650 messages
Chat Pages: 1546  1545  1544  1543  1542  1541  1540  1539  1538  1537  1536  1535  Older
DateSubjectAuthorDiscuss
27/7/2017
13:51
Think any SRPT takeover more likely to be their paper plus cash sweetener.
wildbunch
27/7/2017
12:20
No its just MMs closing gap between us and nasdaq imo hoping to generate a bit of interest ! And they drew out a 10k buy it seems.
luminoso
27/7/2017
10:21
With no logged buys or sales ... almost an hour into trading and the share price moves up from 197.5 to £2? EDIT @ 11.20 am ... 84 buys and 961 sells, produces one of the largest AIM share price hikes in a while ... is this NASDAQ traders ( yet unpublished trades )buying cheap on AIM?
hugus maximus
26/7/2017
21:59
Final close $13.62 which at todays exchange rate is £2.08 & again is ahead of AIM which is slowly catching up also note there were a large number of transaction today 51,197.Clearly an increase in interest in Summit state side fuelling the notion that SRPT may have their own interest in SMMT.
chrisatrdg
26/7/2017
20:17
$13.89 up 0.89 (6.85%)
football
26/7/2017
15:50
I think others have a similar view to the one expressed re SRPT and the cash.
waterloo01
26/7/2017
15:23
Great potential again today on NASDAQ ... does anyone have a view about whether this is simply riding on Sarepta's coattails or is this as a result of renewed interest in Summit? (Or perhaps both?)
hugus maximus
26/7/2017
11:36
Glaxo spent $130 million in the second quarter acquiring a priority review voucher to expedite the Food and Drug Administration's assessment. Haven't SUMM got one of those? More than the market cap.
solomon
26/7/2017
08:33
Hugus - I don't think your speech-to-text app is working correctly.
solomon
26/7/2017
08:24
MMs clearly playing a different game with the share price to the world that they allow us to be are privy to. EDIT for Solomon! Whoops.
hugus maximus
25/7/2017
23:04
At current exchange rates NASDAQ close is £2 based on a $13 close hopefully this will be reflected on AIM Wednesday.
chrisatrdg
25/7/2017
22:07
£13 close USA
football
25/7/2017
18:22
Apologies Waterloo ... of course ... you meant a 52 week high ... I was assuming you meant the year "2017". Last autumn Sarepeta's licensing deal prompted a huge share price spike. Hoping eager anticipation is met with something concrete re: RDZ deal, the NASDAQ may indeed have no idea of Summit's C Diff drug.
hugus maximus
25/7/2017
17:47
52 week high was $19.75 according to Nasdaq. Just about to hit $13.00
waterloo01
25/7/2017
17:20
SMMT is one of Zacks' big tips (again). I guess we are all too long in the market (and tooth) to be entertained by such an upstart.
solomon
25/7/2017
16:27
Many interesting thoughts there Waterloo and sparky Luminoso. Edit ... did you mean "year high - $13"?
hugus maximus
25/7/2017
15:33
Hugus, I don't expect it to drop back but if anything move closer to the year high ($19.00 or there about). Broker consensus is around $24/$28 and certainly any RDZ positive news would see this drive higher (don't think that many in the US are even aware of RDZ). Otherwise, as I posted a last week, if the current trial is unequivocal, then can't see SRPT paying 45% of ongoing trial costs without US rights, however our major holders will want a major return, so who knows at what price? However, they have the money now, so wouldn't be that surprised to see some deal constructed where they secure all rights in return for cash/serious milestones on this phase results and on approvals or even a merger of some sort. All IMO
waterloo01
25/7/2017
15:17
Only in my dreams, Hugus ! Nasdaq started sparky.
luminoso
25/7/2017
15:00
Luminoso ... so talk of £20 parties no longer anticipated?
hugus maximus
25/7/2017
14:53
Waterloo - the NASDAQ seems to be holding above $12.50 as requested!
hugus maximus
25/7/2017
14:47
Another scenario that I have never considered before is SRPT taking all of the DMD programme off us and leaving us with C.Diff and a shed load of cash. Well, a few sheds......
luminoso
25/7/2017
14:45
I'll take it !
luminoso
25/7/2017
12:54
Yep, they could offer just over £9 per share with their available funds.
solomon
25/7/2017
12:09
Buy Summit?
chrisatrdg
25/7/2017
12:08
$300M in cash, $100M line of credit, $325M raise . . . What's Sarepta going to do with all that $$?
waterloo01
Chat Pages: 1546  1545  1544  1543  1542  1541  1540  1539  1538  1537  1536  1535  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170727 12:55:24